- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-07-0022151

Sparvens Pharmaceutical Private Limited
About Sparvens Pharmaceutical Private Limited
Data last updated:
Sparvens Pharmaceutical Private Limited is a private limited company based in Nalgonda, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 September 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85190TG2022PTC166811.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sahitya Sudha Mayi Yarlagadda and Naresh Arikatla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Pl No O N. S Dam, Nalgonda, Telangana, India – 508202.
Sparvens Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-07-0022151).
Company details
Recognitions & Rankings of Sparvens Pharmaceutical
Contact details
Sparvens Pharmaceutical Private Limited's registered office is in Nalgonda, Telangana.
- Registered AddressPl No O N. S Dam, Nalgonda, Telangana, India – 508202
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sparvens Pharmaceutical Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2022-23 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Sparvens Pharmaceutical Private Limited, buy the company report.
Board of directors of Sparvens Pharmaceutical Private Limited
Sparvens Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahitya Sudha Mayi Yarlagadda | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
| Naresh Arikatla | Director | 19 Sep 2022 | 4 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Sparvens Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sparvens Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sparvens Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sparvens Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Naresh Arikatla was appointed as Director on 19 Sep 2022.
Frequently asked questions
Sparvens Pharmaceutical is an active private limited company based in Nalgonda, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 September 2022 (4+ years old) and is registered under CIN U85190TG2022PTC166811.
Sparvens Pharmaceutical has 2 current directors:
- Sahitya Sudha Mayi Yarlagadda - Director
- Naresh Arikatla - Director
The latest financial statements of Sparvens Pharmaceutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sparvens Pharmaceutical is U85190TG2022PTC166811. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sparvens Pharmaceutical was incorporated on 19 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Naresh Arikatla was appointed as Director on 19 Sep 2022. Sahitya Sudha Mayi Yarlagadda was appointed as Director on 19 Sep 2022.
Yes, Sparvens Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-07-0022151).
The registered office of Sparvens Pharmaceutical is at Pl No O N. S Dam, Nalgonda, Telangana, India – 508202.
Sparvens Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sparvens Pharmaceutical can be reached at its registered office: Pl No O N. S Dam, Nalgonda, Telangana, India – 508202.

